Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Overexpression of the amplified Pip4k2β gene from 17q11–12 in breast cancer cells confers proliferation advantage

Abstract

Gene amplification is common in solid tumors and is associated with adverse prognosis, disease progression, and development of drug resistance. A small segment from chromosome 17q11–12 containing the HER-2/Neu gene is amplified in about 25% of breast cancer. HER-2/Neu amplification is associated with adverse prognosis and may predict response to chemotherapy and hormonal manipulation. Moreover, HER-2/Neu amplification may select patients for anti-HER-2/Neu-based therapy with Herceptin. We and others recently described a common sequence element from the HER-2/Neu region that was amplified in breast cancer cells. In addition, most, if not all, of the amplified genes from this region display overexpression. This raises the intriguing possibility that genes immediately adjacent to HER-2/Neu may influence the biological behavior of breast cancer carrying HER-2/Neu amplification and serve as rational targets for therapy. By extracting sequence information from public databases, we have constructed a contig in bacterial artificial chromosomes (BACs) that extends from HER-2/Neu to a phosphotidylinositol phosphate kinase (PIPK), Pip4k2β from 17q11–12. Although a role of PI-3-kinase and AKT in cancer biology has been previously described, PIPK has not been previously implicated. We show that Pip4k2β, initially known as Pip5k2β, is amplified in a subset of breast cancer cell lines and primary breast cancer samples that carry HER-2/Neu amplification. Out of eight breast cancer cell lines with HER-2/Neu amplification, three have concomitant amplification of the Pip4k2β gene – UACC-812, BT-474 and ZR-75-30. Similarly, two out of four primary breast tumors with HER-2/Neu amplification carry Pip4k2β gene amplification. Intriguingly, one tumor displays an increase in the gene copy number of Pip4k2β that is significantly more than that of HER-2/Neu. Moreover, dual color FISH reveals that amplified Pip4k2β gene may exist in a distinct structure from that of HER-2/Neu in ZR-75-30 cell line. These studies suggest that Pip4k2β may reside on an amplification maximum distinct from that of HER-2/Neu and serve as an independent target for amplification and selective retention. Pip4k2β amplification is associated with overexpression at the RNA and protein level in breast cancer cell lines. Stable expression of Pip4k2β in breast cancer cell lines with and without HER-2/Neu amplification increases cell proliferation and anchorage-independent growth. The above observations implicate Pip4k2β in the development and/or progression of breast cancer. Our study suggests that Pip4k2β may be a distinct target for gene amplification and selective retention from 17q11–12.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Nadia Harbeck, Frédérique Penault-Llorca, … Fatima Cardoso

References

  • Amler LC and Schwab M . (1989). Mol. Cell. Biol., 9, 4903–4913.

    Article  CAS  Google Scholar 

  • Anderson RA, Boronenkov IV, Doughman SD, Kunz J and Loijens JC . (1999). J. Biol. Chem., 274, 9907–9910.

    Article  CAS  Google Scholar 

  • Arneson LS, Kunz J, Anderson RA and Traub LM . (1999). J. Biol. Chem., 274, 17794–17805.

    Article  CAS  Google Scholar 

  • Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, Sauter G, Kallioniemi O-P and Kallioniemi A . (2000). Cancer Res., 60, 5340–5344.

  • Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Panici PB, Mancuso S, Neri G and Testa JR . (1995). Int. J. Cancer, 64, 280–285.

    Article  CAS  Google Scholar 

  • Brien TP, Odze RD, Sheehan CE, McKenna BJ and Ross JS . (2000). Hum. Pathol., 31, 35–39.

  • Bringuier PP, Tamimi Y, Schuuring E and Schalken J . (1996). Oncogene, 12, 1747–1753.

  • Castellino AM, Parker GJ, Boronenkov IV, Anderson RA and Chao MV . (1997). J. Biol. Chem., 272, 5861–5870.

    Article  CAS  Google Scholar 

  • Chazin VR, Kaleko M, Miller AD and Slamon DJ . (1992). Oncogene, 7, 1859–1866.

  • Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR . (1992). Proc. Natl. Acad. Sci. USA, 89, 9267–9271.

  • Cheng JQ, Ruggeri B, Klein WM, Sonoda G, Altomare DA, Watson DK and Testa JR . (1996). Proc. Natl. Acad. Sci. USA, 93, 3636–3641.

  • Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA . (1987). Science, 237, 178–182.

    Article  CAS  Google Scholar 

  • Fruman DA, Meyers RE and Cantley LC . (1998). Annu. Rev. Biochem., 67, 481–507.

    Article  CAS  Google Scholar 

  • Gary JD, Wurmser AE, Bonangelino CJ, Weisman LS and Emr SD . (1998). J. Cell. Biol., 143, 65–79.

  • Gaudray P, Szepetowski P, Escot C, Birnbaum D and Theillet C . (1992). Mutat. Res., 276, 317–328.

  • Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ . (1992). Proc. Natl. Acad. Sci. USA, 89, 10578–10582.

  • Hay JC, Fisette PL, Jenkins GH, Fukami K, Takenawa T, Anderson RA and Martin TF . (1995). Nature, 374, 173–177.

    Article  CAS  Google Scholar 

  • Homma K, Terui S, Minemura M, Qadota H, Anraku Y, Kanaho Y and Ohya Y . (1998). J. Biol. Chem., 273, 15779–15786.

    Article  CAS  Google Scholar 

  • Huang CL, Feng S and Hilgemann DW . (1998). Nature, 391, 803–806.

    Article  CAS  Google Scholar 

  • Hudziak RM, Schlessinger J and Ullrich A . (1987). Proc. Natl. Acad. Sci. USA, 84, 7159–7163.

  • Ishihara H, Shibasaki Y, Kizuki N, Wada T, Yazaki Y, Asano T and Oka Y . (1998). J. Biol. Chem., 273, 8741–8748.

    Article  CAS  Google Scholar 

  • Ishikawa T, Kobayashi M, Mai M, Suzuki T and Ooi A . (1997). Am. J. Pathol., 151, 761–768.

  • Kauraniemi P, Barlund M, Monni O and Kallioniemi A . (2001). Cancer Res., 61, 8235–8240.

  • Kunz J, Wilson MP, Kisseleva M, Hurley JH, Majerus PW and Anderson RA . (2000). Mol. Cell, 5, 1–11.

  • Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A and Peters G . (1991). Oncogene, 6, 439–444.

  • Lammie GA and Peters G . (1991). Cancer Cells, 3, 413–420.

  • Luoh SW . (2002). Cancer Genet. Cytogenet., 136, 43–47.

  • Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM and Gray JW . (2002). Cancer Res., 62, 3636–3640.

  • McEwen RK, Dove SK, Cooke FT, Painter GF, Holmes AB, Shisheva A, Ohya Y, Parker PJ and Michell RH . (1999). J. Biol. Chem., 274, 33905–33912.

    Article  CAS  Google Scholar 

  • Mejillano M, Yamamoto M, Rozelle AL, Sun HQ, Wang X and Yin HL . (2001). J. Biol. Chem., 276, 1865–1872.

  • Monni O, Barlund M, Mousses S, Kononen J, Sauter G, Heiskanen M, Paavola P, Avela K, Chen Y, Bittner ML and Kallioniemi A . (2001). Proc. Natl. Acad. Sci. USA, 98, 5711–5716.

  • Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M and Henderson IC . (1994). N. Engl. J. Med., 330, 1260–1266.

  • Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T and Nakano H . (1999). Cancer, 85, 1894–1902.

    Article  CAS  Google Scholar 

  • Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F and Lichter P . (1998). Genes Chromosomes Cancer, 23, 307–316.

  • Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, Fisher ER, Lippman ME, Wickerham DL and Wolmark N . (1998). J. Natl. Cancer Inst., 90, 1361–1370.

  • Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R and Slamon DJ . (2000). J. Clin. Oncol., 18, 3651–3664.

  • Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ . (1995). Oncogene, 10, 2435–2446.

  • Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M and Akita R . (1993). Cancer Res., 53, 4960–4970.

  • Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ and Batsakis JG . (1994). Cancer Res., 54, 5675–5682.

  • Proctor AJ, Coombs LM, Cairns JP and Knowles MA . (1991). Oncogene, 6, 789–795.

  • Rameh LE, Tolias KF, Duckworth BC and Cantley LC . (1997). Nature, 390, 192–196.

    Article  CAS  Google Scholar 

  • Rao VD, Misra S, Boronenkov IV, Anderson RA and Hurley JH . (1998). Cell, 94, 829–839.

    Article  CAS  Google Scholar 

  • Ravdin PM and Chamness GC . (1995). Gene, 159, 19–27.

    Article  CAS  Google Scholar 

  • Roelofs H, Schuuring E, Wiegant J, Michalides R and Giphart-Gassler M . (1993). Genes Chromosomes Cancer, 7, 74–84.

  • Rolitsky CD, Theil KS, McGaughy VR, Copeland LJ and Niemann TH . (1999). Int. J. Gynecol. Pathol., 18, 138–143.

  • Ross JS and Fletcher JA . (1999). Semin. Cancer Biol., 9, 125–138.

  • Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, Fisher HA and Muraca PJ . (1997). Hum. Pathol., 28, 827–833.

  • Rozenvayn N and Flaumenhaft R . (2001). J. Biol. Chem., 276, 22410–22419.

    Article  CAS  Google Scholar 

  • Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Benard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J and Sommelet D . (1997). J. Clin. Oncol., 15, 1171–1182.

  • Savelyeva L and Schwab M . (2001). Cancer Lett., 167, 115–123.

  • Sbrissa D, Ikonomov OC and Shisheva A . (1999). J. Biol. Chem., 274, 21589–21597.

    Article  CAS  Google Scholar 

  • Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY and Hammond D . (1985). N. Engl. J. Med., 313, 1111–1116.

  • Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V and Kitchen P . (1993). J. Clin. Oncol., 11, 1936–1942.

  • Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB and Gray JW . (1999). Nat. Genet., 21, 99–102.

  • Shibasaki Y, Ishihara H, Kizuki N, Asano T, Oka Y and Yazaki Y . (1997). J. Biol. Chem., 272, 7578–7581.

    Article  CAS  Google Scholar 

  • Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL . (1987). Science, 235, 177–182.

    Article  CAS  Google Scholar 

  • Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF . (1989). Science, 244, 707–712.

    Article  CAS  Google Scholar 

  • Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J and Norton L . (2001). N. Engl. J. Med., 344, 783–792.

  • Szepetowski P, Courseaux A, Carle GF, Theillet C and Gaudray P . (1992). Oncogene, 7, 751–755.

  • Szepetowski P, Perucca-Lostanlen D and Gaudray P . (1993). Genomics, 16, 745–750.

    Article  CAS  Google Scholar 

  • Theillet C, Adnane J, Szepetowski P, Simon MP, Jeanteur P, Birnbaum D and Gaudray P . (1990). Oncogene, 5, 147–149.

  • Thor AD, Berry DA, Budman DR, Muss HB, Kute T, Henderson IC, Barcos M, Cirrincione C, Edgerton S, Allred C, Norton L and Liu ET . (1998). J. Natl. Cancer Inst., 90, 1346–1360.

  • Tolias KF, Rameh LE, Ishihara H, Shibasaki Y, Chen J, Prestwich GD, Cantley LC and Carpenter CL . (1998). J. Biol. Chem., 273, 18040–18046.

    Article  CAS  Google Scholar 

  • Walch AK, Zitzelsberger HF, Bink K, Hutzler P, Bruch J, Braselmann H, Aubele MM, Mueller J, Stein H, Siewert JR, Hofler H and Werner M . (2000). Mod. Pathol., 13, 814–824.

  • Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC and Couch FJ . (2001). Cancer Res., 61, 4951–4955.

  • Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD and Couch FJ . (2000). Cancer Res., 60, 5371–5375.

  • Zhang X, Loijens JC, Boronenkov IV, Parker GJ, Norris FA, Chen J, Thum O, Prestwich GD, Majerus PW and Anderson RA . (1997). J. Biol. Chem., 272, 17756–17761.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I (S-WL) thank Drs Dennis J Slamon and Owen N Witte for mentorship and support. We thank Drs Bob Franco, Tom Clemans, Jeff Kanuf, and Peter Stambrook for careful review of the manuscripts. S-WL was a recepient of Fellow Scholarship from American Society of Hematology. This paper is dedicated to the loving memory of late Dr Ching-Shuenn Luoh.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luoh, SW., Venkatesan, N. & Tripathi, R. Overexpression of the amplified Pip4k2β gene from 17q11–12 in breast cancer cells confers proliferation advantage. Oncogene 23, 1354–1363 (2004). https://doi.org/10.1038/sj.onc.1207251

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207251

Keywords

This article is cited by

Search

Quick links